|
Volumn 1, Issue 2, 2000, Pages 146-155
|
Myocardial protection by the nitroderivative of aspirin, NCX 4016: in vitro and in vivo experiments in the rabbit.
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
6 OXOPROSTAGLANDIN F1 ALPHA;
ACETYLSALICYLIC ACID;
ACETYLSALICYLIC ACID 3 (NITROXYMETHYL)PHENYL ESTER;
ANGIOTENSIN II;
CREATINE KINASE;
DRUG DERIVATIVE;
NITRIC OXIDE;
PEROXIDASE;
VASOCONSTRICTOR AGENT;
ANIMAL;
ARTICLE;
DOSE RESPONSE;
DRUG EFFECT;
ELECTROCARDIOGRAPHY;
HEART INFARCTION;
HEART LEFT VENTRICLE FUNCTION;
HEART MUSCLE;
IN VITRO STUDY;
MALE;
METABOLISM;
PATHOPHYSIOLOGY;
RABBIT;
REPERFUSION INJURY;
6-KETOPROSTAGLANDIN F1 ALPHA;
ANGIOTENSIN II;
ANIMALS;
ASPIRIN;
CREATINE KINASE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ELECTROCARDIOGRAPHY;
MALE;
MYOCARDIAL INFARCTION;
MYOCARDIAL REPERFUSION INJURY;
MYOCARDIUM;
NITRIC OXIDE;
PEROXIDASE;
RABBITS;
VASOCONSTRICTOR AGENTS;
VENTRICULAR FUNCTION, LEFT;
|
EID: 0034136964
PISSN: 1129471X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (53)
|
References (0)
|